Page 2 - David Devos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

For patients newly diagnosed with Parkinson disease, deferiprone is associated with worse scores in measures of parkinsonism.

Prince Albert Housing Authority is looking for a Contractor to operate the Kitchen in Carment Court Senior Hig...

AstraZeneca expects to deliver less than half target In a story the pharmaceutical company has not denied, Reuters reports that AstraZeneca has told the European Union during internal meetings that it “would deliver less than 90 million doses” of its covid-19 vaccine in the second quarter  of this year. That is less than half the Covid-19 vaccines it was contracted to supply and follows a shortfall in the first quarter. A later statement from AstraZeneca said it was attempting to increase productivity in an effort to fulfil the contract. An EU official told Reuters the bloc should still ...

AbFero Pharmaceuticals Announces Funding From Cure Parkinson's For Lead Compound SP-420 Second Parkinson's Grant to Clinical Stage Pharmaceutical Company Developing Iron Chelators HARWELL, England, Feb. 17, 2021 /PRNewswire/ -- AbFero Ltd., a subsidiary of AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, today announced the award of a grant from Cure Parkinson's for the development of their lead, brain-penetrant iron chelating agent, SP-420, as a disease modifying therapy for Parkinson's disease (PD). The fu...